Alberta is opening COVID-19 vaccine boosters to all Albertans aged 18 and older while launching an ambitious booster shot campaign to protect Albertans from the rapidly spreading Omicron variant.
Alberta’s government is the first in Canada to fully cover the cost of the injectable opioid treatment drug Sublocade. The treatment lasts in a person’s system for 30 days, providing stabilization, reduced craving and significantly enhanced
Alberta’s government has funded more than 8,000 addiction treatment spaces annually, doubling the original commitment made in 2019 and firmly establishing Alberta as a national leader in treating addiction.
Zolgensma, a one-time gene therapy used to treat spinal muscular atrophy, will change the lives of eligible Alberta children as it is now part of the Rare Diseases Drug Coverage Program.